Cargando…

Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016

Cyclic nucleotide phosphodiesterases (PDEs) represent one of the key targets in the research field of intracellular signaling related to the second messenger molecules cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP). Hence, non-invasive imaging of this enzyme class...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schröder, Susann, Scheunemann, Matthias, Wenzel, Barbara, Brust, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068090/ https://www.ncbi.nlm.nih.gov/pubmed/33917199 http://dx.doi.org/10.3390/ijms22083832

Ejemplares similares

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
por: Schröder, Susann, et al.
Publicado: (2016)

Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
por: Ritawidya, Rien, et al.
Publicado: (2019)

Investigation of an (18)F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
por: Schröder, Susann, et al.
Publicado: (2018)

Synthesis, (18)F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
por: Schröder, Susann, et al.
Publicado: (2015)

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
por: Schirrmacher, Ralf, et al.
Publicado: (2019)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)
por: Lan, Yu, et al.
Publicado: (2019)

Editorial: Positron Emission Tomography (PET) Imaging of Brain Biochemistry: Beyond High-Affinity Radioligands
por: Kilbourn, Michael R., et al.
Publicado: (2022)

Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia
por: Kubota, Manabu, et al.
Publicado: (2022)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Cyclic nucleotide specific phosphodiesterases of Leishmania major
por: Johner, Andrea, et al.
Publicado: (2006)

Cyclic nucleotide phosphodiesterases – 40 years of progress
por: Beavo, Joseph A, et al.
Publicado: (2009)

Cyclic nucleotide phosphodiesterase 1 and vascular aging
por: Yan, Chen
Publicado: (2015)

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
por: Dude, Iulia, et al.
Publicado: (2017)

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates
por: Raval, Nakul Ravi, et al.
Publicado: (2022)

Cyclic AMP compartments and signaling specificity: Role of cyclic nucleotide phosphodiesterases
por: Conti, Marco, et al.
Publicado: (2014)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography
por: Huang, Yangjie, et al.
Publicado: (2020)

Development of Novel (11)C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging
por: Rong, Jian, et al.
Publicado: (2023)

Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
por: Mittal, Rahul, et al.
Publicado: (2017)

[(11)C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)
por: Gourand, Fabienne, et al.
Publicado: (2015)

Phosphodiesterases Maintain Signaling Fidelity via Compartmentalization of Cyclic Nucleotides
por: Lomas, Oliver, et al.
Publicado: (2014)

Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
por: Brocke, Stefan, et al.
Publicado: (2022)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
por: Gambaryan, Stepan, et al.
Publicado: (2023)

Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2014)

Radiosynthesis and Preclinical Evaluation of an (18)F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
por: Wenzel, Barbara, et al.
Publicado: (2022)

LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine—A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2016)

Expression and Regulation of Cyclic Nucleotide Phosphodiesterases in Human and Rat Pancreatic Islets
por: Heimann, Emilia, et al.
Publicado: (2010)

Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure
por: Preedy, Michael E. J.
Publicado: (2020)

Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota
por: Hou, Xueqin, et al.
Publicado: (2022)

To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
por: Zheng, Yang, et al.
Publicado: (2023)

Quantitation of the A(2A) Adenosine Receptor Density in the Striatum of Mice and Pigs with [(18)F]FLUDA by Positron Emission Tomography
por: Gündel, Daniel, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Positron emission tomography; viable tool in patients pre-CABG?
por: van der Wall, E. E., et al.
Publicado: (2010)

Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity
por: Brescia, Marcella, et al.
Publicado: (2016)

Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers
por: Campolo, Federica, et al.
Publicado: (2023)

Radiosynthesis and Evaluation of an (18)F-Labeled Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate Receptor Subtype 4 (mGlu(4))
por: Kil, Kun-Eek, et al.
Publicado: (2014)

Voxel level quantification of [(11)C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography
por: Rusjan, Pablo M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9ade2inermcv13ajk8ugkrpo8l